nodes	percent_of_prediction	percent_of_DWPC	metapath
Estradiol—NR1I2—esophageal cancer	0.258	0.575	CbGaD
Estradiol—CYP1B1—esophageal cancer	0.148	0.33	CbGaD
Estradiol—SLCO1C1—Methotrexate—esophageal cancer	0.0443	0.133	CbGbCtD
Estradiol—ABCC10—Methotrexate—esophageal cancer	0.0443	0.133	CbGbCtD
Estradiol—ABCB1—esophageal cancer	0.0425	0.0948	CbGaD
Estradiol—AOX1—Methotrexate—esophageal cancer	0.0419	0.126	CbGbCtD
Estradiol—SLCO1B3—Methotrexate—esophageal cancer	0.0247	0.0744	CbGbCtD
Estradiol—SLC22A2—Cisplatin—esophageal cancer	0.0239	0.0718	CbGbCtD
Estradiol—SLC22A11—Methotrexate—esophageal cancer	0.0229	0.0687	CbGbCtD
Estradiol—ABCG2—Carboplatin—esophageal cancer	0.0206	0.062	CbGbCtD
Estradiol—ABCG2—Cisplatin—esophageal cancer	0.0176	0.053	CbGbCtD
Estradiol—SLCO1A2—Methotrexate—esophageal cancer	0.0153	0.0459	CbGbCtD
Estradiol—SLCO1B1—Methotrexate—esophageal cancer	0.0144	0.0433	CbGbCtD
Estradiol—SLC22A8—Methotrexate—esophageal cancer	0.0133	0.04	CbGbCtD
Estradiol—CYP2C9—Capecitabine—esophageal cancer	0.013	0.0391	CbGbCtD
Estradiol—ABCG2—Methotrexate—esophageal cancer	0.0114	0.0344	CbGbCtD
Estradiol—ALB—Methotrexate—esophageal cancer	0.00789	0.0237	CbGbCtD
Estradiol—CYP2C9—Cisplatin—esophageal cancer	0.00655	0.0197	CbGbCtD
Estradiol—ABCB1—Cisplatin—esophageal cancer	0.00636	0.0191	CbGbCtD
Estradiol—ABCB1—Methotrexate—esophageal cancer	0.00413	0.0124	CbGbCtD
Estradiol—FABP2—epithelium—esophageal cancer	0.00221	0.0602	CbGeAlD
Estradiol—GPER1—smooth muscle tissue—esophageal cancer	0.00193	0.0526	CbGeAlD
Estradiol—FABP2—digestive system—esophageal cancer	0.00168	0.0458	CbGeAlD
Estradiol—NR1I2—digestive system—esophageal cancer	0.00128	0.0347	CbGeAlD
Estradiol—FABP2—lymph node—esophageal cancer	0.000961	0.0261	CbGeAlD
Estradiol—ESRRA—bronchus—esophageal cancer	0.000918	0.025	CbGeAlD
Estradiol—GPER1—lymph node—esophageal cancer	0.000871	0.0237	CbGeAlD
Estradiol—ESRRA—trachea—esophageal cancer	0.000825	0.0224	CbGeAlD
Estradiol—ESR2—neck—esophageal cancer	0.000823	0.0224	CbGeAlD
Estradiol—SHBG—neck—esophageal cancer	0.0008	0.0217	CbGeAlD
Estradiol—ESRRA—digestive system—esophageal cancer	0.000709	0.0193	CbGeAlD
Estradiol—SLCO4A1—bronchus—esophageal cancer	0.000622	0.0169	CbGeAlD
Estradiol—SLCO1B3—lung—esophageal cancer	0.00061	0.0166	CbGeAlD
Estradiol—ESRRA—lung—esophageal cancer	0.000592	0.0161	CbGeAlD
Estradiol—SLC22A11—digestive system—esophageal cancer	0.000582	0.0158	CbGeAlD
Estradiol—ESR1—neck—esophageal cancer	0.000563	0.0153	CbGeAlD
Estradiol—ESR2—epithelium—esophageal cancer	0.00056	0.0152	CbGeAlD
Estradiol—SLCO4A1—trachea—esophageal cancer	0.000558	0.0152	CbGeAlD
Estradiol—Ethinyl Estradiol—NR1I2—esophageal cancer	0.00054	0.207	CrCbGaD
Estradiol—ESR2—smooth muscle tissue—esophageal cancer	0.000539	0.0147	CbGeAlD
Estradiol—AOX1—bronchus—esophageal cancer	0.000531	0.0144	CbGeAlD
Estradiol—ABCC10—bronchus—esophageal cancer	0.000516	0.014	CbGeAlD
Estradiol—UGT1A1—digestive system—esophageal cancer	0.000508	0.0138	CbGeAlD
Estradiol—SLC22A2—digestive system—esophageal cancer	0.000506	0.0137	CbGeAlD
Estradiol—SLCO4A1—digestive system—esophageal cancer	0.00048	0.0131	CbGeAlD
Estradiol—AOX1—trachea—esophageal cancer	0.000476	0.013	CbGeAlD
Estradiol—ABCC10—trachea—esophageal cancer	0.000464	0.0126	CbGeAlD
Estradiol—Drostanolone—CYP19A1—esophageal cancer	0.000455	0.175	CrCbGaD
Estradiol—SLC22A3—smooth muscle tissue—esophageal cancer	0.000432	0.0118	CbGeAlD
Estradiol—ESR2—digestive system—esophageal cancer	0.000426	0.0116	CbGeAlD
Estradiol—SLCO1B1—digestive system—esophageal cancer	0.000422	0.0115	CbGeAlD
Estradiol—AOX1—digestive system—esophageal cancer	0.00041	0.0111	CbGeAlD
Estradiol—ESRRA—lymph node—esophageal cancer	0.000405	0.011	CbGeAlD
Estradiol—SLCO4A1—lung—esophageal cancer	0.000401	0.0109	CbGeAlD
Estradiol—ABCC10—digestive system—esophageal cancer	0.000399	0.0108	CbGeAlD
Estradiol—CYP1B1—smooth muscle tissue—esophageal cancer	0.000397	0.0108	CbGeAlD
Estradiol—AR—epithelium—esophageal cancer	0.00039	0.0106	CbGeAlD
Estradiol—AR—bronchus—esophageal cancer	0.000385	0.0105	CbGeAlD
Estradiol—ESR1—epithelium—esophageal cancer	0.000383	0.0104	CbGeAlD
Estradiol—AR—smooth muscle tissue—esophageal cancer	0.000376	0.0102	CbGeAlD
Estradiol—SLCO2B1—digestive system—esophageal cancer	0.000374	0.0102	CbGeAlD
Estradiol—ESR1—smooth muscle tissue—esophageal cancer	0.000369	0.01	CbGeAlD
Estradiol—ESR2—lung—esophageal cancer	0.000356	0.00967	CbGeAlD
Estradiol—SLCO1A2—digestive system—esophageal cancer	0.000344	0.00935	CbGeAlD
Estradiol—AOX1—lung—esophageal cancer	0.000342	0.00931	CbGeAlD
Estradiol—SLCO1C1—lymph node—esophageal cancer	0.000342	0.00931	CbGeAlD
Estradiol—ABCC10—lung—esophageal cancer	0.000333	0.00906	CbGeAlD
Estradiol—CYP1B1—digestive system—esophageal cancer	0.000314	0.00853	CbGeAlD
Estradiol—SLCO2B1—lung—esophageal cancer	0.000312	0.00849	CbGeAlD
Estradiol—AR—digestive system—esophageal cancer	0.000297	0.00808	CbGeAlD
Estradiol—ESR1—digestive system—esophageal cancer	0.000292	0.00793	CbGeAlD
Estradiol—CYP1A1—epithelium—esophageal cancer	0.000291	0.00793	CbGeAlD
Estradiol—SLCO1A2—lung—esophageal cancer	0.000287	0.00781	CbGeAlD
Estradiol—CYP1A1—bronchus—esophageal cancer	0.000287	0.00781	CbGeAlD
Estradiol—SLC22A3—lung—esophageal cancer	0.000285	0.00775	CbGeAlD
Estradiol—CYP2C19—digestive system—esophageal cancer	0.000275	0.00749	CbGeAlD
Estradiol—SLCO4A1—lymph node—esophageal cancer	0.000274	0.00746	CbGeAlD
Estradiol—Estrone—CYP1B1—esophageal cancer	0.00027	0.104	CrCbGaD
Estradiol—CYP1B1—lung—esophageal cancer	0.000262	0.00713	CbGeAlD
Estradiol—CYP1A1—trachea—esophageal cancer	0.000258	0.00701	CbGeAlD
Estradiol—AR—lung—esophageal cancer	0.000248	0.00675	CbGeAlD
Estradiol—ESR1—lung—esophageal cancer	0.000244	0.00662	CbGeAlD
Estradiol—ESR2—lymph node—esophageal cancer	0.000243	0.00662	CbGeAlD
Estradiol—Ethinyl Estradiol—ABCC2—esophageal cancer	0.000242	0.0927	CrCbGaD
Estradiol—AOX1—lymph node—esophageal cancer	0.000234	0.00637	CbGeAlD
Estradiol—ABCC10—lymph node—esophageal cancer	0.000228	0.0062	CbGeAlD
Estradiol—CYP1A2—digestive system—esophageal cancer	0.000225	0.00611	CbGeAlD
Estradiol—CYP1A1—digestive system—esophageal cancer	0.000222	0.00603	CbGeAlD
Estradiol—CYP3A5—digestive system—esophageal cancer	0.000217	0.0059	CbGeAlD
Estradiol—SLCO2B1—lymph node—esophageal cancer	0.000213	0.0058	CbGeAlD
Estradiol—CYP2C9—digestive system—esophageal cancer	0.000213	0.0058	CbGeAlD
Estradiol—Conjugated Estrogens—ABCC2—esophageal cancer	0.000211	0.081	CrCbGaD
Estradiol—ALB—lymph node—esophageal cancer	0.000195	0.00531	CbGeAlD
Estradiol—ABCG2—lung—esophageal cancer	0.000195	0.00531	CbGeAlD
Estradiol—SLC22A3—lymph node—esophageal cancer	0.000195	0.0053	CbGeAlD
Estradiol—CYP1A2—lung—esophageal cancer	0.000188	0.00511	CbGeAlD
Estradiol—CYP1A1—lung—esophageal cancer	0.000185	0.00504	CbGeAlD
Estradiol—CYP3A5—lung—esophageal cancer	0.000181	0.00493	CbGeAlD
Estradiol—CYP1B1—lymph node—esophageal cancer	0.000179	0.00487	CbGeAlD
Estradiol—AR—lymph node—esophageal cancer	0.00017	0.00462	CbGeAlD
Estradiol—ESR1—lymph node—esophageal cancer	0.000167	0.00453	CbGeAlD
Estradiol—Testosterone—CYP1B1—esophageal cancer	0.000164	0.063	CrCbGaD
Estradiol—Estriol—ABCB1—esophageal cancer	0.000163	0.0624	CrCbGaD
Estradiol—CYP3A4—digestive system—esophageal cancer	0.000163	0.00443	CbGeAlD
Estradiol—Migraine—Capecitabine—esophageal cancer	0.000161	0.00201	CcSEcCtD
Estradiol—Skin exfoliation—Methotrexate—esophageal cancer	0.000161	0.002	CcSEcCtD
Estradiol—Vaginal infection—Methotrexate—esophageal cancer	0.000159	0.00197	CcSEcCtD
Estradiol—Face oedema—Capecitabine—esophageal cancer	0.000158	0.00197	CcSEcCtD
Estradiol—Irritability—Capecitabine—esophageal cancer	0.000157	0.00195	CcSEcCtD
Estradiol—Mood swings—Capecitabine—esophageal cancer	0.000155	0.00193	CcSEcCtD
Estradiol—Neoplasm—Methotrexate—esophageal cancer	0.000152	0.00189	CcSEcCtD
Estradiol—Urine output increased—Methotrexate—esophageal cancer	0.000152	0.00189	CcSEcCtD
Estradiol—Bladder pain—Methotrexate—esophageal cancer	0.000152	0.00189	CcSEcCtD
Estradiol—Urinary tract disorder—Cisplatin—esophageal cancer	0.000152	0.00189	CcSEcCtD
Estradiol—Liver function test abnormal—Capecitabine—esophageal cancer	0.000151	0.00188	CcSEcCtD
Estradiol—ABCB1—epithelium—esophageal cancer	0.000151	0.00412	CbGeAlD
Estradiol—Estramustine—ABCB1—esophageal cancer	0.000151	0.058	CrCbGaD
Estradiol—Connective tissue disorder—Cisplatin—esophageal cancer	0.000151	0.00188	CcSEcCtD
Estradiol—Urethral disorder—Cisplatin—esophageal cancer	0.000151	0.00188	CcSEcCtD
Estradiol—Gynaecomastia—Methotrexate—esophageal cancer	0.000151	0.00187	CcSEcCtD
Estradiol—Dry skin—Capecitabine—esophageal cancer	0.00015	0.00187	CcSEcCtD
Estradiol—Abdominal pain upper—Capecitabine—esophageal cancer	0.00015	0.00186	CcSEcCtD
Estradiol—Visual impairment—Cisplatin—esophageal cancer	0.000148	0.00184	CcSEcCtD
Estradiol—Breast disorder—Capecitabine—esophageal cancer	0.000148	0.00184	CcSEcCtD
Estradiol—Nasopharyngitis—Capecitabine—esophageal cancer	0.000147	0.00182	CcSEcCtD
Estradiol—Gastritis—Capecitabine—esophageal cancer	0.000145	0.0018	CcSEcCtD
Estradiol—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000145	0.0018	CcSEcCtD
Estradiol—Eye disorder—Cisplatin—esophageal cancer	0.000144	0.00179	CcSEcCtD
Estradiol—Tinnitus—Cisplatin—esophageal cancer	0.000144	0.00178	CcSEcCtD
Estradiol—Lymphadenopathy—Methotrexate—esophageal cancer	0.000143	0.00178	CcSEcCtD
Estradiol—Flushing—Cisplatin—esophageal cancer	0.000143	0.00178	CcSEcCtD
Estradiol—Cardiac disorder—Cisplatin—esophageal cancer	0.000143	0.00178	CcSEcCtD
Estradiol—Abdominal distension—Capecitabine—esophageal cancer	0.000143	0.00177	CcSEcCtD
Estradiol—Dysphagia—Capecitabine—esophageal cancer	0.000142	0.00176	CcSEcCtD
Estradiol—Asthma—Capecitabine—esophageal cancer	0.000142	0.00176	CcSEcCtD
Estradiol—Influenza—Capecitabine—esophageal cancer	0.000142	0.00176	CcSEcCtD
Estradiol—Thrombophlebitis—Methotrexate—esophageal cancer	0.000141	0.00175	CcSEcCtD
Estradiol—Bronchospasm—Capecitabine—esophageal cancer	0.000139	0.00173	CcSEcCtD
Estradiol—Polyuria—Methotrexate—esophageal cancer	0.000139	0.00173	CcSEcCtD
Estradiol—Immune system disorder—Cisplatin—esophageal cancer	0.000139	0.00173	CcSEcCtD
Estradiol—Mediastinal disorder—Cisplatin—esophageal cancer	0.000139	0.00172	CcSEcCtD
Estradiol—Sweating increased—Capecitabine—esophageal cancer	0.000138	0.00172	CcSEcCtD
Estradiol—Bronchitis—Capecitabine—esophageal cancer	0.000136	0.0017	CcSEcCtD
Estradiol—Alopecia—Cisplatin—esophageal cancer	0.000136	0.00169	CcSEcCtD
Estradiol—Abdominal discomfort—Capecitabine—esophageal cancer	0.000136	0.00169	CcSEcCtD
Estradiol—Malnutrition—Cisplatin—esophageal cancer	0.000134	0.00167	CcSEcCtD
Estradiol—Erythema—Cisplatin—esophageal cancer	0.000134	0.00167	CcSEcCtD
Estradiol—ABCB1—trachea—esophageal cancer	0.000134	0.00364	CbGeAlD
Estradiol—ABCG2—lymph node—esophageal cancer	0.000133	0.00363	CbGeAlD
Estradiol—Flatulence—Cisplatin—esophageal cancer	0.000132	0.00164	CcSEcCtD
Estradiol—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000132	0.00164	CcSEcCtD
Estradiol—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000129	0.00161	CcSEcCtD
Estradiol—Weight increased—Capecitabine—esophageal cancer	0.000129	0.0016	CcSEcCtD
Estradiol—Visual disturbance—Methotrexate—esophageal cancer	0.000129	0.0016	CcSEcCtD
Estradiol—Muscle spasms—Cisplatin—esophageal cancer	0.000129	0.0016	CcSEcCtD
Estradiol—Weight decreased—Capecitabine—esophageal cancer	0.000128	0.00159	CcSEcCtD
Estradiol—Hyperglycaemia—Capecitabine—esophageal cancer	0.000128	0.00159	CcSEcCtD
Estradiol—Pneumonia—Capecitabine—esophageal cancer	0.000127	0.00158	CcSEcCtD
Estradiol—CYP1A1—lymph node—esophageal cancer	0.000127	0.00345	CbGeAlD
Estradiol—Infestation NOS—Capecitabine—esophageal cancer	0.000126	0.00157	CcSEcCtD
Estradiol—Infestation—Capecitabine—esophageal cancer	0.000126	0.00157	CcSEcCtD
Estradiol—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000126	0.00157	CcSEcCtD
Estradiol—Depression—Capecitabine—esophageal cancer	0.000126	0.00157	CcSEcCtD
Estradiol—Tremor—Cisplatin—esophageal cancer	0.000126	0.00156	CcSEcCtD
Estradiol—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000125	0.00155	CcSEcCtD
Estradiol—Lethargy—Methotrexate—esophageal cancer	0.000125	0.00155	CcSEcCtD
Estradiol—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000125	0.00155	CcSEcCtD
Estradiol—Ill-defined disorder—Cisplatin—esophageal cancer	0.000124	0.00155	CcSEcCtD
Estradiol—Myocardial infarction—Capecitabine—esophageal cancer	0.000124	0.00154	CcSEcCtD
Estradiol—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000124	0.00154	CcSEcCtD
Estradiol—Jaundice—Capecitabine—esophageal cancer	0.000123	0.00153	CcSEcCtD
Estradiol—Urinary tract infection—Capecitabine—esophageal cancer	0.000123	0.00153	CcSEcCtD
Estradiol—Conjunctivitis—Capecitabine—esophageal cancer	0.000123	0.00153	CcSEcCtD
Estradiol—Osteoarthritis—Methotrexate—esophageal cancer	0.000122	0.00152	CcSEcCtD
Estradiol—Malaise—Cisplatin—esophageal cancer	0.000121	0.0015	CcSEcCtD
Estradiol—Haematuria—Capecitabine—esophageal cancer	0.000121	0.0015	CcSEcCtD
Estradiol—Testosterone—CYP19A1—esophageal cancer	0.000121	0.0462	CrCbGaD
Estradiol—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00012	0.00149	CcSEcCtD
Estradiol—Epistaxis—Capecitabine—esophageal cancer	0.000119	0.00148	CcSEcCtD
Estradiol—Irritability—Methotrexate—esophageal cancer	0.000117	0.00145	CcSEcCtD
Estradiol—Mood swings—Methotrexate—esophageal cancer	0.000116	0.00144	CcSEcCtD
Estradiol—ABCB1—digestive system—esophageal cancer	0.000115	0.00313	CbGeAlD
Estradiol—Myalgia—Cisplatin—esophageal cancer	0.000114	0.00142	CcSEcCtD
Estradiol—Haemoglobin—Capecitabine—esophageal cancer	0.000114	0.00142	CcSEcCtD
Estradiol—Rhinitis—Capecitabine—esophageal cancer	0.000114	0.00141	CcSEcCtD
Estradiol—Anxiety—Cisplatin—esophageal cancer	0.000114	0.00141	CcSEcCtD
Estradiol—Haemorrhage—Capecitabine—esophageal cancer	0.000114	0.00141	CcSEcCtD
Estradiol—Hepatitis—Capecitabine—esophageal cancer	0.000114	0.00141	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000113	0.00141	CcSEcCtD
Estradiol—Hypoaesthesia—Capecitabine—esophageal cancer	0.000113	0.0014	CcSEcCtD
Estradiol—Liver function test abnormal—Methotrexate—esophageal cancer	0.000113	0.0014	CcSEcCtD
Estradiol—Discomfort—Cisplatin—esophageal cancer	0.000113	0.0014	CcSEcCtD
Estradiol—Pharyngitis—Capecitabine—esophageal cancer	0.000113	0.0014	CcSEcCtD
Estradiol—Urinary tract disorder—Capecitabine—esophageal cancer	0.000112	0.00139	CcSEcCtD
Estradiol—Oedema peripheral—Capecitabine—esophageal cancer	0.000112	0.00139	CcSEcCtD
Estradiol—Connective tissue disorder—Capecitabine—esophageal cancer	0.000112	0.00139	CcSEcCtD
Estradiol—Urethral disorder—Capecitabine—esophageal cancer	0.000111	0.00138	CcSEcCtD
Estradiol—Breast disorder—Methotrexate—esophageal cancer	0.00011	0.00137	CcSEcCtD
Estradiol—Oedema—Cisplatin—esophageal cancer	0.000109	0.00136	CcSEcCtD
Estradiol—Anaphylactic shock—Cisplatin—esophageal cancer	0.000109	0.00136	CcSEcCtD
Estradiol—Visual impairment—Capecitabine—esophageal cancer	0.000109	0.00136	CcSEcCtD
Estradiol—Infection—Cisplatin—esophageal cancer	0.000109	0.00135	CcSEcCtD
Estradiol—Erythema multiforme—Capecitabine—esophageal cancer	0.000107	0.00133	CcSEcCtD
Estradiol—Nervous system disorder—Cisplatin—esophageal cancer	0.000107	0.00133	CcSEcCtD
Estradiol—Tachycardia—Cisplatin—esophageal cancer	0.000107	0.00133	CcSEcCtD
Estradiol—Skin disorder—Cisplatin—esophageal cancer	0.000106	0.00132	CcSEcCtD
Estradiol—Eye disorder—Capecitabine—esophageal cancer	0.000106	0.00132	CcSEcCtD
Estradiol—Tinnitus—Capecitabine—esophageal cancer	0.000106	0.00132	CcSEcCtD
Estradiol—Hyperhidrosis—Cisplatin—esophageal cancer	0.000106	0.00131	CcSEcCtD
Estradiol—Asthma—Methotrexate—esophageal cancer	0.000106	0.00131	CcSEcCtD
Estradiol—Cardiac disorder—Capecitabine—esophageal cancer	0.000105	0.00131	CcSEcCtD
Estradiol—Flushing—Capecitabine—esophageal cancer	0.000105	0.00131	CcSEcCtD
Estradiol—Pancreatitis—Methotrexate—esophageal cancer	0.000103	0.00129	CcSEcCtD
Estradiol—Angiopathy—Capecitabine—esophageal cancer	0.000103	0.00128	CcSEcCtD
Estradiol—Immune system disorder—Capecitabine—esophageal cancer	0.000103	0.00127	CcSEcCtD
Estradiol—Mediastinal disorder—Capecitabine—esophageal cancer	0.000102	0.00127	CcSEcCtD
Estradiol—Chills—Capecitabine—esophageal cancer	0.000102	0.00127	CcSEcCtD
Estradiol—Abdominal discomfort—Methotrexate—esophageal cancer	0.000101	0.00126	CcSEcCtD
Estradiol—Alopecia—Capecitabine—esophageal cancer	0.0001	0.00125	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	9.97e-05	0.00124	CcSEcCtD
Estradiol—Mental disorder—Capecitabine—esophageal cancer	9.94e-05	0.00124	CcSEcCtD
Estradiol—Malnutrition—Capecitabine—esophageal cancer	9.88e-05	0.00123	CcSEcCtD
Estradiol—Erythema—Capecitabine—esophageal cancer	9.88e-05	0.00123	CcSEcCtD
Estradiol—Paraesthesia—Cisplatin—esophageal cancer	9.82e-05	0.00122	CcSEcCtD
Estradiol—Upper respiratory tract infection—Methotrexate—esophageal cancer	9.81e-05	0.00122	CcSEcCtD
Estradiol—Dyspnoea—Cisplatin—esophageal cancer	9.75e-05	0.00121	CcSEcCtD
Estradiol—Flatulence—Capecitabine—esophageal cancer	9.74e-05	0.00121	CcSEcCtD
Estradiol—Dysgeusia—Capecitabine—esophageal cancer	9.68e-05	0.0012	CcSEcCtD
Estradiol—Photosensitivity reaction—Methotrexate—esophageal cancer	9.64e-05	0.0012	CcSEcCtD
Estradiol—ABCB1—lung—esophageal cancer	9.62e-05	0.00262	CbGeAlD
Estradiol—Back pain—Capecitabine—esophageal cancer	9.56e-05	0.00119	CcSEcCtD
Estradiol—Decreased appetite—Cisplatin—esophageal cancer	9.51e-05	0.00118	CcSEcCtD
Estradiol—Muscle spasms—Capecitabine—esophageal cancer	9.5e-05	0.00118	CcSEcCtD
Estradiol—Pneumonia—Methotrexate—esophageal cancer	9.47e-05	0.00118	CcSEcCtD
Estradiol—Gastrointestinal disorder—Cisplatin—esophageal cancer	9.44e-05	0.00117	CcSEcCtD
Estradiol—Infestation NOS—Methotrexate—esophageal cancer	9.41e-05	0.00117	CcSEcCtD
Estradiol—Infestation—Methotrexate—esophageal cancer	9.41e-05	0.00117	CcSEcCtD
Estradiol—Depression—Methotrexate—esophageal cancer	9.39e-05	0.00117	CcSEcCtD
Estradiol—Pain—Cisplatin—esophageal cancer	9.35e-05	0.00116	CcSEcCtD
Estradiol—Tremor—Capecitabine—esophageal cancer	9.26e-05	0.00115	CcSEcCtD
Estradiol—Ill-defined disorder—Capecitabine—esophageal cancer	9.17e-05	0.00114	CcSEcCtD
Estradiol—Conjunctivitis—Methotrexate—esophageal cancer	9.15e-05	0.00114	CcSEcCtD
Estradiol—Feeling abnormal—Cisplatin—esophageal cancer	9.01e-05	0.00112	CcSEcCtD
Estradiol—Haematuria—Methotrexate—esophageal cancer	8.97e-05	0.00112	CcSEcCtD
Estradiol—Malaise—Capecitabine—esophageal cancer	8.91e-05	0.00111	CcSEcCtD
Estradiol—Hepatobiliary disease—Methotrexate—esophageal cancer	8.9e-05	0.00111	CcSEcCtD
Estradiol—Ethinyl Estradiol—ABCB1—esophageal cancer	8.9e-05	0.0341	CrCbGaD
Estradiol—Epistaxis—Methotrexate—esophageal cancer	8.88e-05	0.0011	CcSEcCtD
Estradiol—Vertigo—Capecitabine—esophageal cancer	8.88e-05	0.0011	CcSEcCtD
Estradiol—Syncope—Capecitabine—esophageal cancer	8.86e-05	0.0011	CcSEcCtD
Estradiol—Palpitations—Capecitabine—esophageal cancer	8.73e-05	0.00109	CcSEcCtD
Estradiol—Loss of consciousness—Capecitabine—esophageal cancer	8.68e-05	0.00108	CcSEcCtD
Estradiol—Body temperature increased—Cisplatin—esophageal cancer	8.65e-05	0.00107	CcSEcCtD
Estradiol—Cough—Capecitabine—esophageal cancer	8.62e-05	0.00107	CcSEcCtD
Estradiol—Hypertension—Capecitabine—esophageal cancer	8.53e-05	0.00106	CcSEcCtD
Estradiol—Haemoglobin—Methotrexate—esophageal cancer	8.49e-05	0.00106	CcSEcCtD
Estradiol—Haemorrhage—Methotrexate—esophageal cancer	8.45e-05	0.00105	CcSEcCtD
Estradiol—Hepatitis—Methotrexate—esophageal cancer	8.45e-05	0.00105	CcSEcCtD
Estradiol—Arthralgia—Capecitabine—esophageal cancer	8.41e-05	0.00105	CcSEcCtD
Estradiol—Myalgia—Capecitabine—esophageal cancer	8.41e-05	0.00105	CcSEcCtD
Estradiol—Chest pain—Capecitabine—esophageal cancer	8.41e-05	0.00105	CcSEcCtD
Estradiol—Pharyngitis—Methotrexate—esophageal cancer	8.39e-05	0.00104	CcSEcCtD
Estradiol—Anxiety—Capecitabine—esophageal cancer	8.38e-05	0.00104	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	8.35e-05	0.00104	CcSEcCtD
Estradiol—Urinary tract disorder—Methotrexate—esophageal cancer	8.34e-05	0.00104	CcSEcCtD
Estradiol—Discomfort—Capecitabine—esophageal cancer	8.31e-05	0.00103	CcSEcCtD
Estradiol—Urethral disorder—Methotrexate—esophageal cancer	8.28e-05	0.00103	CcSEcCtD
Estradiol—Dry mouth—Capecitabine—esophageal cancer	8.23e-05	0.00102	CcSEcCtD
Estradiol—Visual impairment—Methotrexate—esophageal cancer	8.14e-05	0.00101	CcSEcCtD
Estradiol—Confusional state—Capecitabine—esophageal cancer	8.13e-05	0.00101	CcSEcCtD
Estradiol—Oedema—Capecitabine—esophageal cancer	8.06e-05	0.001	CcSEcCtD
Estradiol—Hypersensitivity—Cisplatin—esophageal cancer	8.06e-05	0.001	CcSEcCtD
Estradiol—Infection—Capecitabine—esophageal cancer	8.01e-05	0.000996	CcSEcCtD
Estradiol—Erythema multiforme—Methotrexate—esophageal cancer	7.99e-05	0.000993	CcSEcCtD
Estradiol—Shock—Capecitabine—esophageal cancer	7.93e-05	0.000986	CcSEcCtD
Estradiol—Nervous system disorder—Capecitabine—esophageal cancer	7.91e-05	0.000983	CcSEcCtD
Estradiol—Eye disorder—Methotrexate—esophageal cancer	7.9e-05	0.000982	CcSEcCtD
Estradiol—Tinnitus—Methotrexate—esophageal cancer	7.88e-05	0.000979	CcSEcCtD
Estradiol—Tachycardia—Capecitabine—esophageal cancer	7.87e-05	0.000978	CcSEcCtD
Estradiol—Asthenia—Cisplatin—esophageal cancer	7.85e-05	0.000976	CcSEcCtD
Estradiol—Cardiac disorder—Methotrexate—esophageal cancer	7.84e-05	0.000975	CcSEcCtD
Estradiol—Skin disorder—Capecitabine—esophageal cancer	7.83e-05	0.000974	CcSEcCtD
Estradiol—Hyperhidrosis—Capecitabine—esophageal cancer	7.8e-05	0.000969	CcSEcCtD
Estradiol—Conjugated Estrogens—ABCB1—esophageal cancer	7.77e-05	0.0298	CrCbGaD
Estradiol—Estrone—ABCB1—esophageal cancer	7.75e-05	0.0297	CrCbGaD
Estradiol—Angiopathy—Methotrexate—esophageal cancer	7.67e-05	0.000953	CcSEcCtD
Estradiol—Immune system disorder—Methotrexate—esophageal cancer	7.63e-05	0.000949	CcSEcCtD
Estradiol—Mediastinal disorder—Methotrexate—esophageal cancer	7.62e-05	0.000947	CcSEcCtD
Estradiol—Chills—Methotrexate—esophageal cancer	7.58e-05	0.000942	CcSEcCtD
Estradiol—Diarrhoea—Cisplatin—esophageal cancer	7.48e-05	0.00093	CcSEcCtD
Estradiol—Alopecia—Methotrexate—esophageal cancer	7.47e-05	0.000928	CcSEcCtD
Estradiol—Mental disorder—Methotrexate—esophageal cancer	7.4e-05	0.00092	CcSEcCtD
Estradiol—Erythema—Methotrexate—esophageal cancer	7.36e-05	0.000914	CcSEcCtD
Estradiol—Malnutrition—Methotrexate—esophageal cancer	7.36e-05	0.000914	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	7.35e-05	0.000913	CcSEcCtD
Estradiol—Insomnia—Capecitabine—esophageal cancer	7.29e-05	0.000907	CcSEcCtD
Estradiol—Paraesthesia—Capecitabine—esophageal cancer	7.24e-05	0.0009	CcSEcCtD
Estradiol—Dysgeusia—Methotrexate—esophageal cancer	7.2e-05	0.000895	CcSEcCtD
Estradiol—Dyspnoea—Capecitabine—esophageal cancer	7.19e-05	0.000894	CcSEcCtD
Estradiol—Back pain—Methotrexate—esophageal cancer	7.11e-05	0.000884	CcSEcCtD
Estradiol—Dyspepsia—Capecitabine—esophageal cancer	7.1e-05	0.000882	CcSEcCtD
Estradiol—Decreased appetite—Capecitabine—esophageal cancer	7.01e-05	0.000871	CcSEcCtD
Estradiol—Gastrointestinal disorder—Capecitabine—esophageal cancer	6.96e-05	0.000865	CcSEcCtD
Estradiol—Vomiting—Cisplatin—esophageal cancer	6.96e-05	0.000865	CcSEcCtD
Estradiol—Fatigue—Capecitabine—esophageal cancer	6.95e-05	0.000864	CcSEcCtD
Estradiol—Rash—Cisplatin—esophageal cancer	6.9e-05	0.000857	CcSEcCtD
Estradiol—Pain—Capecitabine—esophageal cancer	6.9e-05	0.000857	CcSEcCtD
Estradiol—Constipation—Capecitabine—esophageal cancer	6.9e-05	0.000857	CcSEcCtD
Estradiol—Dermatitis—Cisplatin—esophageal cancer	6.89e-05	0.000857	CcSEcCtD
Estradiol—Ill-defined disorder—Methotrexate—esophageal cancer	6.82e-05	0.000848	CcSEcCtD
Estradiol—Feeling abnormal—Capecitabine—esophageal cancer	6.65e-05	0.000826	CcSEcCtD
Estradiol—Malaise—Methotrexate—esophageal cancer	6.63e-05	0.000825	CcSEcCtD
Estradiol—Vertigo—Methotrexate—esophageal cancer	6.61e-05	0.000821	CcSEcCtD
Estradiol—Gastrointestinal pain—Capecitabine—esophageal cancer	6.59e-05	0.00082	CcSEcCtD
Estradiol—ABCB1—lymph node—esophageal cancer	6.58e-05	0.00179	CbGeAlD
Estradiol—Nausea—Cisplatin—esophageal cancer	6.5e-05	0.000808	CcSEcCtD
Estradiol—Cough—Methotrexate—esophageal cancer	6.42e-05	0.000798	CcSEcCtD
Estradiol—Urticaria—Capecitabine—esophageal cancer	6.41e-05	0.000796	CcSEcCtD
Estradiol—Body temperature increased—Capecitabine—esophageal cancer	6.37e-05	0.000792	CcSEcCtD
Estradiol—Abdominal pain—Capecitabine—esophageal cancer	6.37e-05	0.000792	CcSEcCtD
Estradiol—Chest pain—Methotrexate—esophageal cancer	6.26e-05	0.000778	CcSEcCtD
Estradiol—Arthralgia—Methotrexate—esophageal cancer	6.26e-05	0.000778	CcSEcCtD
Estradiol—Myalgia—Methotrexate—esophageal cancer	6.26e-05	0.000778	CcSEcCtD
Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	6.22e-05	0.000773	CcSEcCtD
Estradiol—Discomfort—Methotrexate—esophageal cancer	6.19e-05	0.000769	CcSEcCtD
Estradiol—Confusional state—Methotrexate—esophageal cancer	6.05e-05	0.000752	CcSEcCtD
Estradiol—Anaphylactic shock—Methotrexate—esophageal cancer	6e-05	0.000746	CcSEcCtD
Estradiol—Infection—Methotrexate—esophageal cancer	5.96e-05	0.000741	CcSEcCtD
Estradiol—Hypersensitivity—Capecitabine—esophageal cancer	5.94e-05	0.000739	CcSEcCtD
Estradiol—Nervous system disorder—Methotrexate—esophageal cancer	5.89e-05	0.000732	CcSEcCtD
Estradiol—Skin disorder—Methotrexate—esophageal cancer	5.83e-05	0.000725	CcSEcCtD
Estradiol—Hyperhidrosis—Methotrexate—esophageal cancer	5.8e-05	0.000721	CcSEcCtD
Estradiol—Asthenia—Capecitabine—esophageal cancer	5.79e-05	0.000719	CcSEcCtD
Estradiol—Pruritus—Capecitabine—esophageal cancer	5.71e-05	0.000709	CcSEcCtD
Estradiol—Diarrhoea—Capecitabine—esophageal cancer	5.52e-05	0.000686	CcSEcCtD
Estradiol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	5.47e-05	0.00068	CcSEcCtD
Estradiol—Insomnia—Methotrexate—esophageal cancer	5.43e-05	0.000675	CcSEcCtD
Estradiol—Paraesthesia—Methotrexate—esophageal cancer	5.39e-05	0.00067	CcSEcCtD
Estradiol—Dyspnoea—Methotrexate—esophageal cancer	5.35e-05	0.000665	CcSEcCtD
Estradiol—Somnolence—Methotrexate—esophageal cancer	5.34e-05	0.000663	CcSEcCtD
Estradiol—Dizziness—Capecitabine—esophageal cancer	5.33e-05	0.000663	CcSEcCtD
Estradiol—Dyspepsia—Methotrexate—esophageal cancer	5.28e-05	0.000657	CcSEcCtD
Estradiol—Decreased appetite—Methotrexate—esophageal cancer	5.22e-05	0.000649	CcSEcCtD
Estradiol—Gastrointestinal disorder—Methotrexate—esophageal cancer	5.18e-05	0.000644	CcSEcCtD
Estradiol—Fatigue—Methotrexate—esophageal cancer	5.18e-05	0.000643	CcSEcCtD
Estradiol—Pain—Methotrexate—esophageal cancer	5.13e-05	0.000638	CcSEcCtD
Estradiol—Vomiting—Capecitabine—esophageal cancer	5.13e-05	0.000637	CcSEcCtD
Estradiol—Rash—Capecitabine—esophageal cancer	5.08e-05	0.000632	CcSEcCtD
Estradiol—Dermatitis—Capecitabine—esophageal cancer	5.08e-05	0.000631	CcSEcCtD
Estradiol—Headache—Capecitabine—esophageal cancer	5.05e-05	0.000628	CcSEcCtD
Estradiol—Feeling abnormal—Methotrexate—esophageal cancer	4.95e-05	0.000615	CcSEcCtD
Estradiol—Gastrointestinal pain—Methotrexate—esophageal cancer	4.91e-05	0.00061	CcSEcCtD
Estradiol—Nausea—Capecitabine—esophageal cancer	4.79e-05	0.000595	CcSEcCtD
Estradiol—Urticaria—Methotrexate—esophageal cancer	4.77e-05	0.000593	CcSEcCtD
Estradiol—Abdominal pain—Methotrexate—esophageal cancer	4.75e-05	0.00059	CcSEcCtD
Estradiol—Body temperature increased—Methotrexate—esophageal cancer	4.75e-05	0.00059	CcSEcCtD
Estradiol—Testosterone—ABCB1—esophageal cancer	4.71e-05	0.0181	CrCbGaD
Estradiol—Hypersensitivity—Methotrexate—esophageal cancer	4.42e-05	0.00055	CcSEcCtD
Estradiol—Asthenia—Methotrexate—esophageal cancer	4.31e-05	0.000535	CcSEcCtD
Estradiol—Pruritus—Methotrexate—esophageal cancer	4.25e-05	0.000528	CcSEcCtD
Estradiol—Diarrhoea—Methotrexate—esophageal cancer	4.11e-05	0.000511	CcSEcCtD
Estradiol—Dizziness—Methotrexate—esophageal cancer	3.97e-05	0.000493	CcSEcCtD
Estradiol—Vomiting—Methotrexate—esophageal cancer	3.82e-05	0.000474	CcSEcCtD
Estradiol—Rash—Methotrexate—esophageal cancer	3.79e-05	0.00047	CcSEcCtD
Estradiol—Dermatitis—Methotrexate—esophageal cancer	3.78e-05	0.00047	CcSEcCtD
Estradiol—Headache—Methotrexate—esophageal cancer	3.76e-05	0.000467	CcSEcCtD
Estradiol—Nausea—Methotrexate—esophageal cancer	3.57e-05	0.000443	CcSEcCtD
Estradiol—ALB—Metabolism—GSTT1—esophageal cancer	3.92e-06	3.93e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—TYMP—esophageal cancer	3.91e-06	3.92e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP2A6—esophageal cancer	3.89e-06	3.9e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.88e-06	3.89e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP2A6—esophageal cancer	3.87e-06	3.88e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CA2—esophageal cancer	3.87e-06	3.88e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.86e-06	3.87e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GNG7—esophageal cancer	3.85e-06	3.86e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—ABCB1—esophageal cancer	3.84e-06	3.85e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GAPDH—esophageal cancer	3.82e-06	3.83e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP26A1—esophageal cancer	3.8e-06	3.81e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—NOS3—esophageal cancer	3.79e-06	3.8e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CRABP1—esophageal cancer	3.78e-06	3.79e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TGFBR2—esophageal cancer	3.76e-06	3.77e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ALOX15—esophageal cancer	3.7e-06	3.71e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ALDH2—esophageal cancer	3.7e-06	3.71e-05	CbGpPWpGaD
Estradiol—AOX1—Disease—PIK3CA—esophageal cancer	3.7e-06	3.71e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ENO1—esophageal cancer	3.69e-06	3.7e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS1—esophageal cancer	3.69e-06	3.7e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—ENO1—esophageal cancer	3.67e-06	3.68e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS1—esophageal cancer	3.67e-06	3.68e-05	CbGpPWpGaD
Estradiol—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.67e-06	3.68e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PTGS2—esophageal cancer	3.66e-06	3.67e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—CREBBP—esophageal cancer	3.66e-06	3.67e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PSME1—esophageal cancer	3.64e-06	3.65e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PSME2—esophageal cancer	3.64e-06	3.65e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CYP1B1—esophageal cancer	3.62e-06	3.63e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PSME2—esophageal cancer	3.62e-06	3.63e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PSME1—esophageal cancer	3.62e-06	3.63e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ALDH2—esophageal cancer	3.61e-06	3.62e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.6e-06	3.61e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ADH7—esophageal cancer	3.6e-06	3.61e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GNG7—esophageal cancer	3.6e-06	3.61e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PTGS2—esophageal cancer	3.6e-06	3.61e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—SMAD4—esophageal cancer	3.56e-06	3.57e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—TPI1—esophageal cancer	3.53e-06	3.54e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTO1—esophageal cancer	3.53e-06	3.54e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—GSTT1—esophageal cancer	3.52e-06	3.53e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—CREBBP—esophageal cancer	3.51e-06	3.53e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP2A6—esophageal cancer	3.47e-06	3.49e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.46e-06	3.47e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.46e-06	3.47e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.46e-06	3.47e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—GSTT1—esophageal cancer	3.43e-06	3.44e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CYP1B1—esophageal cancer	3.42e-06	3.43e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CYP19A1—esophageal cancer	3.41e-06	3.42e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.4e-06	3.41e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.39e-06	3.4e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ALDOB—esophageal cancer	3.39e-06	3.4e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ALDH2—esophageal cancer	3.37e-06	3.38e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS1—esophageal cancer	3.29e-06	3.3e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ENO1—esophageal cancer	3.29e-06	3.3e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—CREBBP—esophageal cancer	3.28e-06	3.29e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GAPDH—esophageal cancer	3.26e-06	3.27e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PSME1—esophageal cancer	3.25e-06	3.26e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PSME2—esophageal cancer	3.25e-06	3.26e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CRABP1—esophageal cancer	3.23e-06	3.24e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CYP19A1—esophageal cancer	3.22e-06	3.23e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—ENO1—esophageal cancer	3.22e-06	3.23e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS1—esophageal cancer	3.22e-06	3.23e-05	CbGpPWpGaD
Estradiol—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.21e-06	3.22e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—GSTT1—esophageal cancer	3.21e-06	3.22e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.18e-06	3.19e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP2A6—esophageal cancer	3.17e-06	3.18e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PSME2—esophageal cancer	3.17e-06	3.18e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PSME1—esophageal cancer	3.17e-06	3.18e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.16e-06	3.17e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.16e-06	3.17e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ADH1B—esophageal cancer	3.15e-06	3.16e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—NOS3—esophageal cancer	3.15e-06	3.16e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP1B1—esophageal cancer	3.14e-06	3.15e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP1B1—esophageal cancer	3.12e-06	3.13e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—HMOX1—esophageal cancer	3.11e-06	3.12e-05	CbGpPWpGaD
Estradiol—AOX1—Metabolism—PIK3CA—esophageal cancer	3.09e-06	3.1e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GNG7—esophageal cancer	3.07e-06	3.08e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—CREBBP—esophageal cancer	3.06e-06	3.07e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—EP300—esophageal cancer	3.05e-06	3.06e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—TYMP—esophageal cancer	3.01e-06	3.02e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—CREBBP—esophageal cancer	3.01e-06	3.01e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ENO1—esophageal cancer	3e-06	3.01e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS1—esophageal cancer	3e-06	3.01e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—EP300—esophageal cancer	2.99e-06	3e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—ABCB1—esophageal cancer	2.98e-06	2.99e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PSME2—esophageal cancer	2.96e-06	2.97e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PSME1—esophageal cancer	2.96e-06	2.97e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CYP19A1—esophageal cancer	2.95e-06	2.96e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—HMOX1—esophageal cancer	2.94e-06	2.95e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—NOS3—esophageal cancer	2.94e-06	2.95e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CYP19A1—esophageal cancer	2.93e-06	2.94e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.93e-06	2.94e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—HIF1A—esophageal cancer	2.91e-06	2.92e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—EP300—esophageal cancer	2.88e-06	2.89e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.88e-06	2.89e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ALDH2—esophageal cancer	2.88e-06	2.89e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PTGS2—esophageal cancer	2.88e-06	2.89e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.86e-06	2.87e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.83e-06	2.84e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—ABCB1—esophageal cancer	2.82e-06	2.83e-05	CbGpPWpGaD
Estradiol—AR—Gene Expression—MYC—esophageal cancer	2.82e-06	2.83e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP1B1—esophageal cancer	2.8e-06	2.81e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—KDR—esophageal cancer	2.78e-06	2.79e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—CREBBP—esophageal cancer	2.78e-06	2.79e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—CREBBP—esophageal cancer	2.76e-06	2.77e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—CREBBP—esophageal cancer	2.75e-06	2.76e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—GSTT1—esophageal cancer	2.74e-06	2.75e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—NOS3—esophageal cancer	2.74e-06	2.75e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.73e-06	2.74e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.73e-06	2.73e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—TPI1—esophageal cancer	2.73e-06	2.73e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP2A6—esophageal cancer	2.71e-06	2.72e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.7e-06	2.71e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—HMOX1—esophageal cancer	2.69e-06	2.7e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—NOS3—esophageal cancer	2.69e-06	2.7e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PTGS2—esophageal cancer	2.69e-06	2.69e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—HMOX1—esophageal cancer	2.68e-06	2.69e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.64e-06	2.65e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CYP19A1—esophageal cancer	2.63e-06	2.64e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.63e-06	2.63e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	2.62e-06	2.63e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.61e-06	2.62e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.58e-06	2.59e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—ABCB1—esophageal cancer	2.58e-06	2.59e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.57e-06	2.58e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—ABCB1—esophageal cancer	2.57e-06	2.58e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—CREBBP—esophageal cancer	2.57e-06	2.57e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS1—esophageal cancer	2.57e-06	2.57e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ENO1—esophageal cancer	2.57e-06	2.57e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.55e-06	2.56e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PSME2—esophageal cancer	2.53e-06	2.54e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PSME1—esophageal cancer	2.53e-06	2.54e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.52e-06	2.52e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PTGS2—esophageal cancer	2.51e-06	2.51e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.49e-06	2.5e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—NOS3—esophageal cancer	2.49e-06	2.5e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—NOS3—esophageal cancer	2.47e-06	2.48e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—NOS3—esophageal cancer	2.47e-06	2.47e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PTGS2—esophageal cancer	2.46e-06	2.47e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—HMOX1—esophageal cancer	2.4e-06	2.41e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CYP19A1—esophageal cancer	2.4e-06	2.41e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—EP300—esophageal cancer	2.39e-06	2.4e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CREBBP—esophageal cancer	2.38e-06	2.39e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GNG7—esophageal cancer	2.37e-06	2.38e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.36e-06	2.36e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—HMOX1—esophageal cancer	2.35e-06	2.35e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—ABCB1—esophageal cancer	2.31e-06	2.31e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—NOS3—esophageal cancer	2.3e-06	2.31e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PTGS2—esophageal cancer	2.28e-06	2.29e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PTGS2—esophageal cancer	2.26e-06	2.27e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PTGS2—esophageal cancer	2.26e-06	2.26e-05	CbGpPWpGaD
Estradiol—SLCO1B3—Metabolism—PIK3CA—esophageal cancer	2.25e-06	2.26e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—EP300—esophageal cancer	2.23e-06	2.24e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.22e-06	2.23e-05	CbGpPWpGaD
Estradiol—SLC22A3—Metabolism—PIK3CA—esophageal cancer	2.21e-06	2.22e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.21e-06	2.22e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—HMOX1—esophageal cancer	2.19e-06	2.2e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP1B1—esophageal cancer	2.18e-06	2.19e-05	CbGpPWpGaD
Estradiol—ESR1—Gene Expression—MYC—esophageal cancer	2.17e-06	2.18e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.15e-06	2.16e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—PIK3CA—esophageal cancer	2.13e-06	2.14e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.13e-06	2.14e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—NOS3—esophageal cancer	2.13e-06	2.14e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.11e-06	2.12e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—ABCB1—esophageal cancer	2.1e-06	2.11e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PTGS2—esophageal cancer	2.1e-06	2.11e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.09e-06	2.1e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—EP300—esophageal cancer	2.08e-06	2.09e-05	CbGpPWpGaD
Estradiol—ALB—Hemostasis—TP53—esophageal cancer	2.06e-06	2.07e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CYP19A1—esophageal cancer	2.05e-06	2.06e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—EP300—esophageal cancer	2.05e-06	2.05e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.99e-06	2e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—ERBB2—esophageal cancer	1.99e-06	2e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ENO1—esophageal cancer	1.98e-06	1.99e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.98e-06	1.99e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.95e-06	1.96e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PSME2—esophageal cancer	1.95e-06	1.96e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PSME1—esophageal cancer	1.95e-06	1.96e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.94e-06	1.95e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—EP300—esophageal cancer	1.9e-06	1.9e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—CREBBP—esophageal cancer	1.88e-06	1.89e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—EP300—esophageal cancer	1.88e-06	1.88e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—EP300—esophageal cancer	1.88e-06	1.88e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—HMOX1—esophageal cancer	1.87e-06	1.88e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.84e-06	1.84e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—ABCB1—esophageal cancer	1.8e-06	1.8e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—NOS3—esophageal cancer	1.79e-06	1.79e-05	CbGpPWpGaD
Estradiol—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	1.77e-06	1.78e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CCND1—esophageal cancer	1.76e-06	1.76e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—EP300—esophageal cancer	1.75e-06	1.75e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.74e-06	1.75e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.73e-06	1.73e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—CREBBP—esophageal cancer	1.72e-06	1.72e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	1.7e-06	1.71e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—NOS3—esophageal cancer	1.69e-06	1.69e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.68e-06	1.69e-05	CbGpPWpGaD
Estradiol—UGT1A1—Metabolism—PIK3CA—esophageal cancer	1.65e-06	1.66e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.63e-06	1.64e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EP300—esophageal cancer	1.62e-06	1.62e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.59e-06	1.59e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.58e-06	1.59e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—NOS3—esophageal cancer	1.55e-06	1.55e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PTGS2—esophageal cancer	1.54e-06	1.55e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.54e-06	1.55e-05	CbGpPWpGaD
Estradiol—CYP1B1—Metabolism—PIK3CA—esophageal cancer	1.54e-06	1.55e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—NOS3—esophageal cancer	1.54e-06	1.54e-05	CbGpPWpGaD
Estradiol—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	1.51e-06	1.52e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—CREBBP—esophageal cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.45e-06	1.45e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.41e-06	1.42e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—MYC—esophageal cancer	1.41e-06	1.42e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—PTGS2—esophageal cancer	1.41e-06	1.41e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.41e-06	1.41e-05	CbGpPWpGaD
Estradiol—ABCG2—Metabolism—PIK3CA—esophageal cancer	1.4e-06	1.41e-05	CbGpPWpGaD
Estradiol—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.39e-06	1.39e-05	CbGpPWpGaD
Estradiol—SLC22A2—Metabolism—PIK3CA—esophageal cancer	1.39e-06	1.39e-05	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.39e-06	1.39e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—EGFR—esophageal cancer	1.38e-06	1.38e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—NOS3—esophageal cancer	1.38e-06	1.38e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.36e-06	1.36e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—EP300—esophageal cancer	1.36e-06	1.36e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—NOS3—esophageal cancer	1.35e-06	1.35e-05	CbGpPWpGaD
Estradiol—SLC22A1—Metabolism—PIK3CA—esophageal cancer	1.29e-06	1.3e-05	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—EP300—esophageal cancer	1.28e-06	1.29e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.26e-06	1.27e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—NOS3—esophageal cancer	1.26e-06	1.26e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PTGS2—esophageal cancer	1.23e-06	1.24e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—CREBBP—esophageal cancer	1.2e-06	1.2e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	1.2e-06	1.2e-05	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—EP300—esophageal cancer	1.18e-06	1.18e-05	CbGpPWpGaD
Estradiol—ALB—Metabolism—EP300—esophageal cancer	1.17e-06	1.17e-05	CbGpPWpGaD
Estradiol—ESR1—Signaling Pathways—TP53—esophageal cancer	1.16e-06	1.16e-05	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.15e-06	1.15e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—NOS3—esophageal cancer	1.08e-06	1.08e-05	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—EP300—esophageal cancer	1.05e-06	1.05e-05	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—EP300—esophageal cancer	1.02e-06	1.03e-05	CbGpPWpGaD
Estradiol—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1e-06	1.01e-05	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PTGS2—esophageal cancer	9.84e-07	9.87e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—EP300—esophageal cancer	9.57e-07	9.6e-06	CbGpPWpGaD
Estradiol—CYP1A1—Metabolism—PIK3CA—esophageal cancer	9.49e-07	9.52e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—CREBBP—esophageal cancer	9.27e-07	9.3e-06	CbGpPWpGaD
Estradiol—CYP2C8—Metabolism—PIK3CA—esophageal cancer	8.7e-07	8.73e-06	CbGpPWpGaD
Estradiol—ALB—Metabolism—PIK3CA—esophageal cancer	8.65e-07	8.68e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—NOS3—esophageal cancer	8.3e-07	8.33e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—EP300—esophageal cancer	8.18e-07	8.21e-06	CbGpPWpGaD
Estradiol—CYP2C19—Metabolism—PIK3CA—esophageal cancer	7.77e-07	7.79e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PTGS2—esophageal cancer	7.59e-07	7.61e-06	CbGpPWpGaD
Estradiol—ABCB1—Metabolism—PIK3CA—esophageal cancer	7.58e-07	7.6e-06	CbGpPWpGaD
Estradiol—CYP2C9—Metabolism—PIK3CA—esophageal cancer	7.08e-07	7.1e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—EP300—esophageal cancer	6.31e-07	6.33e-06	CbGpPWpGaD
Estradiol—CYP1A2—Metabolism—PIK3CA—esophageal cancer	6.05e-07	6.07e-06	CbGpPWpGaD
Estradiol—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.67e-07	4.68e-06	CbGpPWpGaD
